105 related articles for article (PubMed ID: 27239314)
61. Diabetic neuropathy and foot complications.
Boulton AJ
Handb Clin Neurol; 2014; 126():97-107. PubMed ID: 25410217
[TBL] [Abstract][Full Text] [Related]
62. A prospective study of risk factors for foot ulceration: the West of Ireland Diabetes Foot Study.
Hurley L; Kelly L; Garrow AP; Glynn LG; McIntosh C; Alvarez-Iglesias A; Avalos G; Dinneen SF
QJM; 2013 Dec; 106(12):1103-10. PubMed ID: 24072752
[TBL] [Abstract][Full Text] [Related]
63. Duration of Diabetes Predicts Aortic Pulse Wave Velocity and Vascular Events in Alström Syndrome.
Paisey RB; Smith J; Carey C; Barrett T; Campbell F; Maffei P; Marshall JD; Paisey C; Steeds RP; Edwards NC; Bunce S; Geberhiwot T
J Clin Endocrinol Metab; 2015 Aug; 100(8):E1116-24. PubMed ID: 26066530
[TBL] [Abstract][Full Text] [Related]
64. Characteristics of diabetic foot ulcers in Western Sydney, Australia.
Haji Zaine N; Burns J; Vicaretti M; Fletcher JP; Begg L; Hitos K
J Foot Ankle Res; 2014; 7(1):39. PubMed ID: 25279002
[TBL] [Abstract][Full Text] [Related]
65. Childhood diabetic neuropathy: functional impairment and non-invasive screening assessment.
Blankenburg M; Kraemer N; Hirschfeld G; Krumova EK; Maier C; Hechler T; Aksu F; Magerl W; Reinehr T; Wiesel T; Zernikow B
Diabet Med; 2012 Nov; 29(11):1425-32. PubMed ID: 22507184
[TBL] [Abstract][Full Text] [Related]
66. Variation in the recorded incidence of amputation of the lower limb in England.
Holman N; Young RJ; Jeffcoate WJ
Diabetologia; 2012 Jul; 55(7):1919-25. PubMed ID: 22398645
[TBL] [Abstract][Full Text] [Related]
67. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy.
Spallone V; Morganti R; D'Amato C; Greco C; Cacciotti L; Marfia GA
Diabet Med; 2012 May; 29(5):578-85. PubMed ID: 22023377
[TBL] [Abstract][Full Text] [Related]
68. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.
Abbott CA; Malik RA; van Ross ER; Kulkarni J; Boulton AJ
Diabetes Care; 2011 Oct; 34(10):2220-4. PubMed ID: 21852677
[TBL] [Abstract][Full Text] [Related]
69. Short-term metabolic change is associated with improvement in measures of diabetic neuropathy: a 1-year placebo cohort analysis.
Perkins BA; Dholasania A; Buchanan RA; Bril V
Diabet Med; 2010 Nov; 27(11):1271-9. PubMed ID: 20950385
[TBL] [Abstract][Full Text] [Related]
70. Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study.
Perkins BA; Orszag A; Ngo M; Ng E; New P; Bril V
Diabetes Care; 2010 Jul; 33(7):1549-54. PubMed ID: 20357373
[TBL] [Abstract][Full Text] [Related]
71. Elevated triglycerides correlate with progression of diabetic neuropathy.
Wiggin TD; Sullivan KA; Pop-Busui R; Amato A; Sima AA; Feldman EL
Diabetes; 2009 Jul; 58(7):1634-40. PubMed ID: 19411614
[TBL] [Abstract][Full Text] [Related]
72. Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy.
Bril V; Tomioka S; Buchanan RA; Perkins BA;
Diabet Med; 2009 Mar; 26(3):240-6. PubMed ID: 19317818
[TBL] [Abstract][Full Text] [Related]
73. Protection from clinical peripheral sensory neuropathy in Alström syndrome in contrast to early-onset type 2 diabetes.
Paisey RB; Paisey RM; Thomson MP; Bower L; Maffei P; Shield JP; Barnett S; Marshall JD
Diabetes Care; 2009 Mar; 32(3):462-4. PubMed ID: 19092165
[TBL] [Abstract][Full Text] [Related]
74. Threshold for detection of diabetic peripheral sensory neuropathy using a range of research grade monofilaments in persons with Type 2 diabetes mellitus.
Thomson MP; Potter J; Finch PM; Paisey RB
J Foot Ankle Res; 2008 Sep; 1(1):9. PubMed ID: 18822166
[TBL] [Abstract][Full Text] [Related]
75. Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.
Fujita Y; Fukushima M; Suzuki H; Taniguchi A; Nakai Y; Kuroe A; Yasuda K; Hosokawa M; Yamada Y; Inagaki N; Seino Y
Diabetes Res Clin Pract; 2008 Apr; 80(1):e16-9. PubMed ID: 18262304
[TBL] [Abstract][Full Text] [Related]
76. Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study.
Davis TM; Yeap BB; Davis WA; Bruce DG
Diabetologia; 2008 Apr; 51(4):562-6. PubMed ID: 18193189
[TBL] [Abstract][Full Text] [Related]
77. Relationship of polyunsaturated fatty acid intake to peripheral neuropathy among adults with diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999 2004.
Tao M; McDowell MA; Saydah SH; Eberhardt MS
Diabetes Care; 2008 Jan; 31(1):93-5. PubMed ID: 17914029
[TBL] [Abstract][Full Text] [Related]
78. Established diabetic neuropathy seems irreversible despite improvements in metabolic and vascular risk markers--a retrospective case-control study in a hospital patient cohort.
Coppini DV; Spruce MC; Thomas P; Masding MG
Diabet Med; 2006 Sep; 23(9):1016-20. PubMed ID: 16922709
[TBL] [Abstract][Full Text] [Related]
79. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study.
Boyko EJ; Ahroni JH; Cohen V; Nelson KM; Heagerty PJ
Diabetes Care; 2006 Jun; 29(6):1202-7. PubMed ID: 16731996
[TBL] [Abstract][Full Text] [Related]
80. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.
Martin CL; Albers J; Herman WH; Cleary P; Waberski B; Greene DA; Stevens MJ; Feldman EL;
Diabetes Care; 2006 Feb; 29(2):340-4. PubMed ID: 16443884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
